Mark C. Lanasa
- Immunology top 5%
- Oncology top 5%
- Genetics top 1%
- Pathology and Forensic Medicine top 2%
- Molecular Biology
- Co-authors
- W. Allen HoggeTait D. ShanafeltJ. Brice WeinbergPaolo GhiaUrvashi SurtiAndy C. RawstronEric P. HoffmanOla Landgren
- Topics
- Chronic Lymphocytic Leukemia Research (48 papers)Lymphoma Diagnosis and Treatment (28 papers)Immunodeficiency and Autoimmune Disorders (23 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Mark C. Lanasa
74 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 87
- Immunology 907
- Oncology 830
- Genetics 812
- Pathology and Forensic Medicine 633
- Molecular Biology 558
Countries citing papers authored by Mark C. Lanasa
This map shows the geographic impact of Mark C. Lanasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Lanasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Lanasa more than expected).
Fields of papers citing papers by Mark C. Lanasa
This network shows the impact of papers produced by Mark C. Lanasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Lanasa. The network helps show where Mark C. Lanasa may publish in the future.
Co-authorship network of co-authors of Mark C. Lanasa
This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Lanasa. A scholar is included among the top collaborators of Mark C. Lanasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Lanasa. Mark C. Lanasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 63 | |
| 2 | 63 | |
| 3 | 26 | |
| 4 | 7 | |
| 5 | 12 | |
| 6 | 12 | |
| 7 | 135 | |
| 8 | 19 | |
| 9 | 11 | |
| 10 | 5 | |
| 11 | 136 | |
| 12 | 12 | |
| 13 | 8 | |
| 14 | 6 | |
| 15 | 49 | |
| 16 | 18 | |
| 17 | 36 | |
| 18 | 102 | |
| 19 | 48 | |
| 20 | 52 |
About Mark C. Lanasa
Mark C. Lanasa is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 76 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (28 papers) and Immunodeficiency and Autoimmune Disorders (23 papers). The work is most often cited by research in Genetics (812 citations), Immunology (907 citations) and Pathology and Forensic Medicine (633 citations). Mark C. Lanasa has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include W. Allen Hogge, Tait D. Shanafelt, J. Brice Weinberg, Paolo Ghia, Urvashi Surti, Andy C. Rawstron, Eric P. Hoffman, Ola Landgren, Jon P. Gockerman and Alicia D. Volkheimer. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.